BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22101916)

  • 1. Translocation of particles deposited in the respiratory system: a systematic review and statistical analysis.
    Nakane H
    Environ Health Prev Med; 2012 Jul; 17(4):263-74. PubMed ID: 22101916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition efficiency of inhaled particles (15-5000 nm) related to breathing pattern and lung function: an experimental study in healthy children and adults.
    Rissler J; Gudmundsson A; Nicklasson H; Swietlicki E; Wollmer P; Löndahl J
    Part Fibre Toxicol; 2017 Apr; 14(1):10. PubMed ID: 28388961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation of inhaled ultrafine particles to the brain.
    Oberdörster G; Sharp Z; Atudorei V; Elder A; Gelein R; Kreyling W; Cox C
    Inhal Toxicol; 2004 Jun; 16(6-7):437-45. PubMed ID: 15204759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of airborne particulates on respiratory tract deposition of inhaled toluene and naphthalene in the rat.
    Roberts SM; Rohr AC; Mikheev VB; Munson J; Sabo-Attwood T
    Inhal Toxicol; 2018 Jan; 30(1):19-28. PubMed ID: 29465005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach to assess the Particulate Matter exposure for the population living around a cement plant: modelling indoor air and particle deposition in the respiratory tract.
    Sánchez-Soberón F; Mari M; Kumar V; Rovira J; Nadal M; Schuhmacher M
    Environ Res; 2015 Nov; 143(Pt A):10-8. PubMed ID: 26408807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation and effects of ultrafine particles outside of the lung.
    Elder A; Oberdörster G
    Clin Occup Environ Med; 2006; 5(4):785-96. PubMed ID: 17110292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition and biokinetics of inhaled nanoparticles.
    Geiser M; Kreyling WG
    Part Fibre Toxicol; 2010 Jan; 7():2. PubMed ID: 20205860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values.
    Oller AR; Oberdörster G
    Regul Toxicol Pharmacol; 2010; 57(2-3):181-94. PubMed ID: 20172011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pulmonary deposition and retention of indium-111 labeled ultrafine carbon particles in healthy individuals.
    Klepczyńska-Nyström A; Sanchez-Crespo A; Andersson M; Falk R; Lundin A; Larsson BM; Svartengren M
    Inhal Toxicol; 2012 Aug; 24(10):645-51. PubMed ID: 22906170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrafine particle-lung interactions: does size matter?
    Kreyling WG; Semmler-Behnke M; Möller W
    J Aerosol Med; 2006; 19(1):74-83. PubMed ID: 16551218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological interactions and toxicity of nanomaterials in the respiratory tract and various approaches of aerosol generation for toxicity testing.
    Creutzenberg O
    Arch Toxicol; 2012 Jul; 86(7):1117-22. PubMed ID: 22418596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry and toxicology of inhaled ultrafine particles.
    Schmid O; Möller W; Semmler-Behnke M; Ferron GA; Karg E; Lipka J; Schulz H; Kreyling WG; Stoeger T
    Biomarkers; 2009 Jul; 14 Suppl 1():67-73. PubMed ID: 19604063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the health effects associated with the inhalation of particle-filtered and whole diesel exhaust.
    Weitekamp CA; Kerr LB; Dishaw L; Nichols J; Lein M; Stewart MJ
    Inhal Toxicol; 2020 Jan; 32(1):1-13. PubMed ID: 32100584
    [No Abstract]   [Full Text] [Related]  

  • 14. National Particle Component Toxicity (NPACT) Initiative: integrated epidemiologic and toxicologic studies of the health effects of particulate matter components.
    Lippmann M; Chen LC; Gordon T; Ito K; Thurston GD
    Res Rep Health Eff Inst; 2013 Oct; (177):5-13. PubMed ID: 24377209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle deposition in airways of chronic respiratory patients exposed to an urban aerosol.
    Horemans B; Van Holsbeke C; Vos W; Darchuk L; Novakovic V; Fontan AC; De Backer J; Van Grieken R; De Backer W; De Wael K
    Environ Sci Technol; 2012 Nov; 46(21):12162-9. PubMed ID: 23035859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of concentrated ambient particles on normal and hypersecretory airways in rats.
    Harkema JR; Keeler G; Wagner J; Morishita M; Timm E; Hotchkiss J; Marsik F; Dvonch T; Kaminski N; Barr E
    Res Rep Health Eff Inst; 2004 Aug; (120):1-68; discussion 69-79. PubMed ID: 15543855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery.
    Möller W; Felten K; Sommerer K; Scheuch G; Meyer G; Meyer P; Häussinger K; Kreyling WG
    Am J Respir Crit Care Med; 2008 Feb; 177(4):426-32. PubMed ID: 17932382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry considerations for animal aerosol inhalation studies.
    Phalen RF; Mendez LB
    Biomarkers; 2009 Jul; 14 Suppl 1(Suppl 1):63-6. PubMed ID: 19604062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculation of hygroscopic particle deposition in the human lung.
    Winkler-Heil R; Ferron G; Hofmann W
    Inhal Toxicol; 2014 Feb; 26(3):193-206. PubMed ID: 24517842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of an aerosol screening model for size-resolved urban aerosols.
    Stanier CO; Lee SR;
    Res Rep Health Eff Inst; 2014 Jun; (179):3-79. PubMed ID: 25145039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.